ISSN 1016-5169 | E-ISSN 1308-4488
pdf
Corrected balloon occlusive diameter to determine device size during percutaneous atrial septal defect closure [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2015; 43(5): 420-426 | DOI: 10.5543/tkda.2015.68217

Corrected balloon occlusive diameter to determine device size during percutaneous atrial septal defect closure

Şakir Arslan1, Göksel Çağırcı1, Nermin Bayar1, Erkan Köklü1, İsa Öner Yüksel1, Selçuk Küçükseymen1, Zehra Erkal1, Çağın Mustafa Üreyen1, Fuat Gündoğdu2, Yekta Gürlertop3, Mustafa Kemal Erol4, Naci Ceviz5
1Antalya Education And Research Hospital, Cardiology Department, Antalya, Turkey
2Atatürk University, Medical School, Cardiology Department, Erzurum, Turkey
3Trakya University, Medical School, Cardiology Department, Edirne, Turkey
4İstanbul Kemerburgaz University, Medical School, Cardiology Department, İstanbul, Turkey
5Atatürk University, Medical School, Pediatric Cardiology Department, Erzurum, Turkey


OBJECTIVE
The aim of this trial was to investigate the impact of corrected balloon occlusive diameter (cBOD) on successful performance of percutaneous atrial septal defect (ASD) closure.

METHOD
The trial comprised 86 patients (60 female, 26 male; mean age 36.5±14.3) on whom percutaneous ASD closure was performed. Patients were evaluated using transesophageal echocardiography (TEE). Relation of the defect to surrounding tissues and size of rims was also investigated. Balloon sizing was performed intraoperatively on all patients. Size of device was ascertained according to both durability of rims and whether or not they formed significant indentation, both of which determine cBOD.

RESULTS
The ASD closure device was successfully implanted in 84 (97.5%) patients. Mean maximum defect size was 17.4±5.9 mm, and mean color flow diameter was 16.8±5.4 mm. Mean maximum defect size at the moment of loss of shunt flow was 18.4±5.9mm with TEE, and 18.8±6.1mm with fluoroscopy. Mean size of Amplatzer occluder device was 20.0±6.5mm. Device embolization was observed in 2 patients. However, no death occurred during or after the procedure.

CONCLUSION
Percutaneous secundum ASD closure is a safe and effective treatment modality in experienced centers. Utilizing corrected balloon occlusive diameter may be of benefit in deciding the size of ASD occluder device.

Keywords: Angioplasty, balloon, atrial septal defects, corrected balloon occlusive diameter; echocardiography

How to cite this article
Şakir Arslan, Göksel Çağırcı, Nermin Bayar, Erkan Köklü, İsa Öner Yüksel, Selçuk Küçükseymen, Zehra Erkal, Çağın Mustafa Üreyen, Fuat Gündoğdu, Yekta Gürlertop, Mustafa Kemal Erol, Naci Ceviz. Corrected balloon occlusive diameter to determine device size during percutaneous atrial septal defect closure. Turk Kardiyol Dern Ars. 2015; 43(5): 420-426

Corresponding Author: Nermin Bayar, Türkiye
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.